Page last updated: 2024-08-18

cyclohexanol and Peripheral Nerve Diseases

cyclohexanol has been researched along with Peripheral Nerve Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aziz, MT; Good, BL; Lowe, DK1
Chu, SH; Cleeland, CS; Geng, Y; Lee, ES; Lee, YJ; Wang, XS1
Cessot, A; Coriat, R; Deplanque, G; Durand, JP; Goldwasser, F; Gornet, JM; Herait, P; Mir, O; Mitry, E; Montheil, V; Raymond, E; Scotte, F; Yataghene, Y1
Alloui, A; Ardid, D; Constandil, L; Eschalier, A; Hernández, A; Laurido, C; Marchand, F; Mondaca, M; Pelissier, T; Soto-Moyano, R1
Alexandre, J; Durand, JP; Goldwasser, F; Guillevin, L1
Andersen, OK; Arendt-Nielsen, L; Disci, R; Kiziltan, E; Koknel Talu, G; Ozyalcin, S; Yucel, A; Yucel, B1
Eguchi, T; Harabuchi, I; Ikeda, M; Kawai, T; Kishi, R; Matsumoto, H; Miyake, H; Sugimoto, R; Yuasa, J1
Moulin, DE; Sumpton, JE1
Härtel, B; Kalso, E; Tasmuth, T1

Reviews

2 review(s) available for cyclohexanol and Peripheral Nerve Diseases

ArticleYear
Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5

    Topics: Antineoplastic Agents; Cyclohexanols; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Milnacipran; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2014
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:2

    Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Carbamazepine; Central Nervous System; Cyclohexanols; Duloxetine Hydrochloride; Epothilones; Humans; Neoplasms; Neuralgia; Oxcarbazepine; Peripheral Nervous System Diseases; Pyrazines; Taxoids; Thalidomide; Thiophenes; Venlafaxine Hydrochloride; Vinca Alkaloids

2015

Trials

3 trial(s) available for cyclohexanol and Peripheral Nerve Diseases

ArticleYear
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2012
The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    European journal of pain (London, England), 2005, Volume: 9, Issue:4

    Topics: Adult; Aged; Analgesics; Chronic Disease; Cyclohexanols; Double-Blind Method; Electric Stimulation; Female; Hot Temperature; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Pain Measurement; Pain Threshold; Pain, Intractable; Peripheral Nervous System Diseases; Physical Stimulation; Placebos; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

2005
Venlafaxine in neuropathic pain following treatment of breast cancer.
    European journal of pain (London, England), 2002, Volume: 6, Issue:1

    Topics: Analgesics; Breast Neoplasms; Cross-Over Studies; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Mastectomy; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Postoperative Complications; Treatment Outcome; Venlafaxine Hydrochloride

2002

Other Studies

4 other study(ies) available for cyclohexanol and Peripheral Nerve Diseases

ArticleYear
Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats.
    Brain research, 2004, May-22, Volume: 1008, Issue:2

    Topics: Animals; Cyclohexanols; Male; Nerve Fibers, Unmyelinated; Peripheral Nervous System Diseases; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Spinal Cord; Venlafaxine Hydrochloride

2004
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
    Anti-cancer drugs, 2005, Volume: 16, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclohexanols; Female; Fructose; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nervous System Diseases; Recovery of Function; Topiramate; Venlafaxine Hydrochloride

2005
Investigation on neurotoxicity of occupational exposure to cyclohexane: a neurophysiological study.
    Occupational and environmental medicine, 1996, Volume: 53, Issue:3

    Topics: Adult; Case-Control Studies; Cyclohexanes; Cyclohexanols; Follow-Up Studies; Humans; Middle Aged; Neural Conduction; Occupational Exposure; Peripheral Nerves; Peripheral Nervous System Diseases

1996
Treatment of neuropathic pain with venlafaxine.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:5

    Topics: Adult; Cyclohexanols; Female; Humans; Pain; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2001